Should all patients receive prophylactic amiodarone therapy before cardiac surgery?
C Michael White
Correspondence Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA
Email cmwhite@harthosp.org
This article has no abstract so we have provided the first paragraph of the full text.
Approximately 25–40% of the 500,000 patients who undergo open heart surgery annually in the US develop postoperative AF, even though the majority of patients are treated with prophylactic 
-blockade.1 Patients with postoperative AF have a higher rate of hemodynamic instability, longer lengths of stay in hospital and a greater risk of stroke than those without postoperative AF.1, 2
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
L-DOPA, dyskinesia and striatal plasticityNature Neuroscience News and Views (01 May 2003)
